Osteoporosis and chronic kidney disease

Area of Science:

• Nephrology
• Endocrinology
• Gerontology

Background:

• Bone disease is a significant complication in chronic kidney disease stage V (CKD-V) patients.
• While renal osteodystrophy is well-studied, osteoporosis in CKD-V remains less understood.
• Hip fractures are common in CKD-V and linked to increased mortality.

Purpose of the Study:

• To review the risk factors for bone loss in CKD-V patients.
• To explore the limited knowledge on adverse outcomes and therapeutic interventions for osteoporosis in this population.
• To highlight the unknown role of bone loss in CKD-V mortality.

Main Methods:

• Literature review of existing studies on osteoporosis in CKD-V.
• Analysis of risk factors for bone loss in CKD-V patients.
• Synthesis of current understanding regarding outcomes and treatments.

Main Results:

• Risk factors for bone loss in CKD-V overlap with the general population, including female gender, Caucasian race, older age, chronic disease, and immobility.
• Chronic acidosis and renal osteodystrophy may also contribute to bone loss.
• Data on adverse outcomes and therapeutic interventions for CKD-V osteoporosis are scarce.

Conclusions:

• CKD-V patients face a high risk of osteoporosis and associated fractures.
• Current treatment strategies for CKD-V-associated osteoporosis emphasize risk-factor modification.
• Further research is needed to understand the impact of osteoporosis and its treatments in CKD-V.